Case report: Plasma cell leukemia secondary to multiple myeloma successfully treated with anti-BCMA CAR-T cell therapy

Chimeric antigen receptor (CAR)-T cell therapy provides an effective salvage treatment for relapsed/refractory multiple myeloma (RRMM) patients. End-stage RRMM with plasma cell leukemia (PCL) transformation is highly aggressive and resistant to conventional therapy. There is an urgent need for new t...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Jingjing, Lin, Yuehui, Zhao, Defeng, Tong, Chunrong, Chang, Alex H., Chen, Wenming, Gao, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533140/
https://www.ncbi.nlm.nih.gov/pubmed/36212423
http://dx.doi.org/10.3389/fonc.2022.901266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533140/
https://www.ncbi.nlm.nih.gov/pubmed/36212423
http://dx.doi.org/10.3389/fonc.2022.901266

Ejemplares similares